6 Papers
Han Xie is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
The Synergism of Natural Compounds and Conventional Therapeutics against Colorectal Cancer Progression and Metastasis.
Zimao Liang,Han Xie,Weixing Shen,Le Shao,L. Zeng,Xingxing Huang,Qi-jian Zhu,Xiangyang Zhai,Keshuai Li,Zejing Qiu,Xinbing Sui,Haibo Cheng,Qibiao Wu +12 more
TL;DR: The synergism of natural compounds and conventional therapeutics has the potential to become a promising therapy for treating colorectal cancer progression and metastases.
19
A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
Yin-Suo Zheng,Xiaoyu Yue,Cheng Fang,Zhu Jia,Yuxiang Chen,Han Xie,Jiajia Zhao,Zhihao Yang,Lianxing Li,Zhigang Chen,Er-Bao Bian,Bing Zhao +11 more
TL;DR: Results indicated that ER stress-related lncRNA risk signature could be a potential treatment target and a prognosis biomarker for glioma patients.
7
A Novel Diagnostic and Therapeutic Strategy for Cancer Patients by Integrating Chinese Medicine Syndrome Differentiation and Precision Medicine
Shu-xian Yu,Zimao Liang,Qi-biao Wu,Lan Shou,Xingxing Huang,Qian-ru Zhu,Han Xie,Ru-yi Mei,Ruonan Zhang,Xiangyang Zhai,Tian Xie,Xin-bing Sui +11 more
TL;DR: Wang et al. as discussed by the authors developed a novel diagnostic and therapeutic strategy "disease-syndrome differentiation-genomic profiling-prescriptions" for cancer patients by CM syndrome differentiation and precision medicine.
The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
Han Xie,Guirui Huang,Jianhua Zou,Qi-jian Zhu,Zimao Liang,Xingxing Huang,Xiangyang Zhai,Ruonan Zhang,Bi Chen,Keshuai Li,Xinbing Sui,Hongsheng Cui,Qibiao Wu +12 more
TL;DR: The findings of this study reveal the relevant key signaling pathways and targets of curcumin as an adjuvant therapy in the treatment of NSCLC, thus providing pharmacological evidence for further experimental research.
4
Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
Qi-jian Zhu,Xingxing Huang,Shuxian Yu,Lan Shou,Ruonan Zhang,Han Xie,Zimao Liang,Xueni Sun,Jiao Feng,Ting Duan,Mingming Zhang,Yu Xiang,Xinbing Sui,Weiwei Jin,Qibiao Wu +14 more
TL;DR: The m6A modification plays an indispensable role in the formation of TME diversity and complexity, thereby serving as a promising predictive biomarker or therapeutic target for patients with CRC recurrence.